Generation of human islets through expansion and differentiation of non-islet pancreatic cells discarded (pancreatic discard) after islet isolation

Pancreas

Volumn 32, Issue 2, 2006, Pages 130-138

  Todorov, Ivan ^a   Omori, Keiko ^a   Pascual, Michael ^a   Rawson, Jeffery ^a   Nair, Indu ^a   Valiente, Luis ^a   Vuong, Tommy ^a   Matsuda, Takeru ^a   Orr, Chris ^a   Ferreri, Kevin ^a   Smith, Craig V ^a   Kandeel, Fouad ^a   Mullen, Yoko ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Ex vivo human islet generation; Islet precursors; Non islet pancreatic cell differentiation

Indexed keywords

AMYLASE; C PEPTIDE; CYTOKERATIN 19; CYTOKERATIN 7; GLUCOSE; INSULIN; TRANSCRIPTION FACTOR PDX 1; TRYPSIN;

ANIMAL EXPERIMENT; ARTICLE; CELL AGGREGATION; CELL DIFFERENTIATION; CELL MATURATION; CELL POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; ISLET LIKE CELL CLUSTER; ISOLATED ORGAN; MONOLAYER CULTURE; MOUSE; NONHUMAN; ORGAN CULTURE TECHNIQUE; ORGAN DONOR; PANCREAS CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL;

CADAVER; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL DIVISION; CELL SEPARATION; HUMANS; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; PANCREAS; TISSUE DONORS;

EID: 33646060715     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpa.0000202945.78331.93     Document Type: Article

References (52)

1. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343:230-238.
2. Bonner-Weir S, Sharma A. Pancreatic stem cells. J Pathol. 2002;197(4):519-526.
3. Lechner A, Habener JF. Stem/progenitor cells derived from adult tissues: potential for the treatment of diabetes mellitus. Am J Physiol Endocrinol Metab. 2003;284:E259-E266.
4. Zhang YQ, Sarvetnick N. Development of cell markers for the identification and expansion of islet progenitor cells. Diabetes Metab Res Rev. 2003;19(5):363-374.
5. Hussain MA, Theise ND. Stem-cell therapy for diabetes mellitus. Lancet. 2004;364(9429):203-205.
6. Trucco M. Regeneration of the pancreatic beta cell. J Clin Invest. 2005;115(1):5-12.
7. Fishman JA, Patience C. Xenotransplantation: infectious risk revisited. Am J Transplant. 2004;4(9):1383-1390.
8. Lumelsky N, Blondel O, Laeng P, et al. Differentiation of embryonic stem cells into insulin secreting structures similar to pancreatic islets. Science. 2001;292:1389-1394.
9. Hori Y, Rulifson IC, Tsai BC, et al. Growth factor inhibitors promote differentiation for insulin producing tissue from embryonic stem cells. Proc Natl Acad Sci U S A. 2002;99:16105-16110.
10. Hansson M, Tonning A, Frandsen U, et al. Artifactual insulin release from differentiated embryonic stem cells. Diabetes. 2004;53(10):2603-2609.
11. Kania G, Blyszczuk P, Wobus AM. The generation of insulin-producing cells from embryonic stem cells-a discussion of controversial findings. Int J Dev Biol. 2004;48(10):1061-1064.
12. Fujikawa T, Oh SH, Pi L, et al. Teratoma formation leads to failure of treatment for type I diabetes using embryonic stem cell-derived insulin-producing cells. Am J Pathol. 2005;166(6):1781-1791.
13. Hori Y, Gu X, Xie X, et al. Differentiation of insulin-producing cells from human neural progenitor cells. PLoS Med. 2005;2(4):e103.
14. Kojima H, Fujimiya M, Matsumura K, et al. NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice. Nat Med. 2003;9(5):596-603.
15. Suzuki A, Nakauchi H, Taniguchi H. Glucagon-like peptide 1 (1-37) converts intestinal epithelial cells into insulin producing cells. Proc Natl Acad Sci U S A. 2003;100:5034-5039.
16. Zalzman M, Gupta S, Giri RK, et al. Reversal of hyperglycemia in mice by using human expandable insulin-producing cells differentiated from fetal liver progenitor cells. Proc Natl Acad Sci U S A. 2003;100(12):7253-7258.
17. Cao LZ, Tang DQ, Horb ME, et al. High glucose is necessary for complete maturation of Pdxl-VP16-expressing hepatic cells into functional insulin-producing cells. Diabetes. 2004;53(12):3168-3178.
18. Bonner-Weir S, Taneja M, Weir GC, et al. In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci U S A. 2000;97:7999-8004.
19. Ramiya VK, Maraist M, Arfors KE, et al. Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nat Med. 2000;6:278-282.
20. Gao R, Ustinov J, Pulkkinen MA, et al. Characterization of endocrine progenitor cells and critical factors for their differentiation in human adult pancreatic cell culture. Diabetes. 2003;52(8):2007-2015.
21. Lechner A, Nolan AL, Blacken RA, et al. Redifferentiation of insulin-secreting cells after in vitro expansion of adult human pancreatic islet tissue. Biochem Biophys Res Commun. 2005;327(2):581-588.
22. Bouwens L. Transdifferentiation versus stem cell hypothesis for the regeneration of islet beta-cells in the pancreas. Microsc Res Tech. 1998;43:332-336.
23. Gmyr V, Kerr-Conte J, Belaich S, et al. Adult human cytokeratin 19-positive cells reexpress insulin promoter factor 1 in vitro: further evidence for pluripotent pancreatic stem cells in humans. Diabetes. 2000;49(10):1671-1680.
24. Baeyens L, De Breuck S, Lardon J, et al. In vitro generation of insulin-producing beta cells from adult exocrine pancreatic cells. Diabetologia. 2005;48(1):49-57.
25. Zulewski H, Abraham EJ, Gerlach MJ, et al. Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine and hepatic phenotypes. Diabetes. 2001;50:521-533.
26. Abraham EJ, Kodama S, Lin JC, et al. Human pancreatic islet-derived progenitor cell engraftment in immunocompetent mice. Am J Pathol. 2004;164(3):817-830.
27. Street CN, Lakey JR, Seeberger K, et al. Heterogenous expression of nestin in human pancreatic tissue precludes its use as an islet precursor marker. J Endocrinol. February 2004;180(2):213-225.
28. Selander L, Edlund H. Nestin is expressed in mesenchymal and not epithelial cells of the developing mouse pancreas. Mech Dev. 2002;113(2):189-192.
29. Humphrey RK, Bucay N, Beattie GM, et al. Characterization and isolation of promoter-defined nestin-positive cells from the human fetal pancreas. Diabetes. 2003;52(10):2519-2525.
30. Masson S, Harrison DJ, Plevris JN, et al. Potential of hematopoietic stem cell therapy in hepatology: a critical review. Stem Cells. 2004;22(6):897-907.
31. Quesenberry PJ, Dooner G, Colvin G, et al. Stem cell biology and the plasticity polemic. Exp Hematol. 2005;33(4):389-394.
32. Kenmochi T, Miyamoto M, Une S, et al. Improved quality and yield of islets isolated from human pancreata using a two-step digestion method. Pancreas. 2000;20(2):184-190.
33. Todorov IT, Werness BA, Wang HQ, et al. HsMCM2/BM28: a novel proliferation marker for human tumors and normal tissues. Lab Invest. 1998;78(1):73-78.
34. Latif ZA, Noel J, Alejandro R. A simple method of staining fresh and cultured islets. Transplantation. 1988;45(4):827-830.
35. Okamoto H. The REG gene family and REG proteins: with special attention to the regeneration of pancreatic beta-cells. J Hepatobiliary Pancreat Surg. 1999;6(3):254-262.
36. Hall PA, Lemoine NR. Rapid acinar to ductal transdifferentiation in cultured human exocrine pancreas. J Pathol. 1992;166(2):97-103.
37. Vila MR, Lloreta J, Real FX. Normal human pancreas cultures display functional ductal characteristics. Lab Invest. 1994;71(3):423-431.
38. Ferber S, Halkin A, Cohen H, et al. Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat Med. 2000;6(5):568-572.
39. Edlund H. Pancreatic organogenesis - developmental mechanisms and implications for therapy. Nat Rev Genet. 2002;3:524-532.
40. Cirulli V, Baetens D, Rutishauser U, et al. Expression of neural cell adhesion molecule (N-CAM) in rat islets and its role in islet cell type segregation. J Cell Sci. 1994;107(pt 6):1429-1436.
41. Dahl U, Sjodin A, Semb H. Cadherins regulate aggregation of pancreatic beta-cells in vivo. Development. 1996;122(9):2895-2902.
42. Otonkoski T, Beattie GM, Mally MI, et al. Nicotinamide is a potent inducer of endocrine differentiation in cultured human fetal pancreatic cells. J Clin Invest. 1993;92(3):1459-1466.
43. Egan JM, Bulotta A, Hui H, et al. GLP-1 receptor agonists are growth and differentiation factors for pancreatic beta cells. Diabetes Metab Res Rev. 2003;19:115-123.
44. Liu W, Chin-Chance C, Lee EJ, et al. Activation of phosphatidylinositol 3-kinase contributes to insulin-like growth factor I-mediated inhibition of pancreatic beta-cell death. Endocrinology. 2002;143(10):3802-3812.
45. Movassat J, Beattie GM, Lopez AD, et al. Keratinocyte growth factor and beta-cell differentiation in human fetal pancreatic endocrine precursor cells. Diabetologia. 2003;46(6):822-829.
46. Wang TC, Bonner-Weir S, Oates PS, et al. Pancreatic gastrin stimulates islet differentiation of transforming growth factor alpha-induced ductular precursor cells. J Clin Invest. 1993;92(3):1349-1356.
47. Rooman I, Lardon J, Bouwens L. Gastrin stimulates beta-cell neogenesis and increases islet mass from transdifferentiated but not from normal exocrine pancreas tissue. Diabetes. 2002;51(3):686-690.
48. Tsunoda T, Furui H, Klandorf K, et al. Functional maturation of porcine fetal pancreatic explants. Transplant Proc. 1989;21(1 pt 3): 2667-2668.
49. Zenilman ME, Magnuson TH, Swinson K, et al. Pancreatic thread protein is mitogenic to pancreatic-derived cells in culture. Gastroenterology. 1996;110:1208-1214.
50. Korbutt CG, Elliott JF, Ao Z, et al. Large scale isolation, growth, and function of porcine neonatal islet cells. J Clin Invest. 1996;97:2119-2129.
51. Shiogama T, Mullen Y, Klandorf H, et al. Growth and functional maturation of cryopreserved human fetal pancreata. Diabetes. 1986;38(suppl 1):284.
52. Beattie GM, Lopez AD, Otonkoski T, et al. Transplantation of human fetal pancreas: fresh vs. cultured fetal islets or ICCS. J Mol Med. 1999;77(1):70-73.